Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDianomi Regulatory News (DNM)

Share Price Information for Dianomi (DNM)

Share Price is delayed by 15 minutes
Get Live Data
21.50    0.00 (0.00%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £6.46m
DNM Live PriceLast checked at - London Stock Exchange

Intraday Dianomi Share Chart

Banking Facilities Update

13 Mar 2023 08:50

RNS Number : 7326S
Dianomi PLC
13 March 2023
 

13 March 2023

Dianomi plc

("Dianomi", the "Company" or the "Group")

Banking Facilities Update

 

Dianomi, a leading provider of native digital advertising services to premium clients in the Business, Finance and Lifestyle sectors, provides a further update with respect to its banking facilities with SVB Financial Group ("SVB") and Silicon Valley Bank UK Limited ('SVBUK').

After receiving a recommendation from the boards of the Federal Deposit Insurance Corporation ("FDIC") and the Federal Reserve, Secretary of Treasury of the U.S. Government Janet Yellen approved actions enabling the FDIC to complete its resolution of SVB, in a manner that fully protects all depositors. Dianomi will therefore have access to all its funds in SVB, amounting to £0.9 million, as from today.

Furthermore, the The Bank of England ("Bank"), in consultation with the Prudential Regulation Authority ("PRA"), HM Treasury ("HMT") and the Financial Conduct Authority ("FCA"), has taken the decision to sell SVBUK to HSBC UK Bank Plc ("HSBC"). HSBC is authorised and supervised by the PRA and the FCA. The Bank and HMT have confirmed that all depositors' money with SVBUK is safe and secure as a result of this transaction. SVBUK's business will continue to be operated normally by SVBUK. Dianomi holds funds totalling £2.9 million with SVBUK.

As a result, Dianomi's financial position has not been affected by the collapse of SVB or SVBUK and its total cash balances are unchanged at circa £9.6 million, with no debt.

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. It forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

For further information contact:

Dianomi

Rupert Hodson (Chief Executive Officer)

Charlotte Stranner (Chief Financial Officer)

 

Tel: +44 (0)207 802 5530

Panmure Gordon (NOMAD and Broker)

Emma Earl/ Freddy Crossley, Corporate Finance

Rupert Dearden, Corporate Broking

 

Tel: +44 (0)207 886 2500

Novella Communications

Tim Robertson / Safia Colebrook

 

Tel: +44 (0)203 151 7008

About Dianomi

Dianomi, established in 2003, is a leading provider of native digital advertising services to premium clients in the Business, Finance and Lifestyle sectors. The Group operates from its offices in London, New York and Sydney. The Group enables premium brands to deliver native advertisements to a targeted audience on the desktop and mobile websites, mobile and tablet applications of premium publishers. It provides over 400 advertisers, including blue chip names such as abrdn, Invesco and Charles Schwab, with access to an international audience of over 500 million devices per month through its partnerships with over 300 premium publishers, including blue chip names such as Reuters, CNN Business and WSJ. Adverts served are contextually relevant to the content of the webpages on which they appear and mirror the style of the page, which enhances reader engagement. http://www.dianomi.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGIGDXSSBDGXX
12
Date   Source Headline
2nd Jun 20267:00 amRNSNotice of AGM
29th May 20267:00 amRNSFinal Results
27th Apr 20264:15 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSHolding(s) in Company
23rd Mar 20267:00 amRNSHolding(s) in Company
19th Mar 20264:15 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSTrading Statement
16th Mar 20267:00 amRNSPartnership with AI Company Dappier
16th Mar 20267:00 amRNSPartnership with AI Company Dappier
24th Sep 20257:00 amRNSHalf-year Report
30th Jun 202511:30 amRNSChange in Registered Office
26th Jun 202511:00 amRNSResult of AGM
4th Jun 20253:30 pmRNSHolding(s) in Company
29th May 202511:00 amRNSHolding(s) in Company
27th May 20257:00 amRNSHolding(s) in Company
27th May 20257:00 amRNSHolding(s) in Company
23rd May 20257:00 amRNSNotice of AGM
19th May 20257:00 amRNSFinal Results
10th Dec 20247:00 amRNSTrading Statement
26th Nov 202410:05 amRNSHolding(s) in Company
6th Nov 20243:10 pmRNSHolding(s) in Company
17th Oct 202410:15 amRNSHolding(s) in Company
14th Oct 202411:34 amRNSHolding(s) in Company
14th Oct 202411:30 amRNSHolding(s) in Company
10th Oct 20247:00 amRNSBoard Change
23rd Sep 20247:00 amRNSHalf-year Report
16th Sep 202410:00 amRNSNotice of Results
18th Jul 20247:15 amRNSTrading Statement
16th Jul 202410:15 amRNSHolding(s) in Company
8th Jul 20241:05 pmRNSHolding(s) in Company
31st May 20242:10 pmRNSResult of AGM
14th May 20247:00 amRNSHolding(s) in Company
8th May 202411:30 amRNSNotice of AGM
1st May 20247:00 amRNSFinal Results
15th Apr 20241:45 pmRNSHolding(s) in Company
19th Mar 202412:50 pmRNSHolding(s) in Company - Correction
8th Mar 202410:25 amRNSHolding(s) in Company
11th Jan 20247:00 amRNSTrading Statement
13th Nov 20237:00 amRNSDirectorate Change
6th Nov 20237:00 amRNSNew Option Schemes
20th Sep 20237:01 amRNSContract Amendment
20th Sep 20237:00 amRNSHalf-year Report
9th Aug 20239:15 amRNSAIM Rule 17 Disclosure
17th Jul 20237:00 amRNSTrading Statement
12th Jul 20237:00 amRNSHolding(s) in Company
1st Jun 20237:09 amRNSResult of AGM
5th May 20237:00 amRNSNotice of AGM
20th Apr 20237:00 amRNSFinal Results
13th Apr 20237:00 amRNSNotice of Results
15th Mar 20237:00 amRNSDirectorate Change
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.